Fiorallo Pharmaceuticals Private Limited
About Fiorallo Pharmaceuticals Private Limited
Data last updated:
Fiorallo Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 18 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2018PTC109380. Its GSTIN is 10AADCF5378C1Z2 (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Arun Kumar and Punam Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shri Alok Johri S/O Dr K S Johri 313 B Flat No. 302 3A Sector 3 Vaishali, Ghaziabad, Uttar Pradesh, India – 201010.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.07 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹707 (net margin 0.3%) and EBITDA of ₹8,156 (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 82% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fiorallo Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressShri Alok Johri S/O Dr K S Johri 313 B Flat No. 302 3A Sector 3 Vaishali, Ghaziabad, Uttar Pradesh, India – 201010
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Fiorallo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fiorallo Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fiorallo Pharmaceuticals Private Limited, buy the company report.
Financials of Fiorallo Pharmaceuticals Private Limited
FY 2025 filings availableFiorallo Pharmaceuticals Private Limited reported revenue of ₹2.07 Lakh (down 31% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 31% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 82%. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8,156 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹707 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fiorallo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fiorallo Pharmaceuticals Private Limited
Fiorallo Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Kumar | Director | 18 Oct 2018 | 8 Years 0 Months | Current |
| Punam Devi | Director | 18 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Fiorallo Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biosense Pharmaceuticals Private Limited | ₹2.08 Lakh (FY 2024) | Patna, Bihar, India | ||||
| Mcchem Pharmaceuticals Private Limited | ₹2.08 Lakh (FY 2018) | 44.0% | Patna, Bihar, India | |||
| Hoper Pharmaceuticals Private Limited | ₹2.08 Lakh (FY 2020) | Edathala, Kerala, India | ||||
| Fiorallo Pharmaceuticals Private Limitedthis company | ₹2.07 Lakh (FY 2024) | ₹707 | 0.3% | -31.0% | Ghaziabad, Uttar Pradesh, India | |
| Orgone Pharmaceuticals Private Limited | ₹2.07 Lakh (FY 2020) | 103.0% | Patna, Bihar, India |
To see the full peer comparison of Fiorallo Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fiorallo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fiorallo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fiorallo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCF5378C1Z2 | Bihar | Active | 07 Jan 2019 |
To see the full GST registrations and return filing status of Fiorallo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fiorallo Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Arun Kumar was appointed as Director on 18 Oct 2018.
Frequently asked questions
Fiorallo Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 18 October 2018 (8+ years old) and is registered under CIN U51909UP2018PTC109380.
Fiorallo Pharmaceuticals has 2 current directors:
- Arun Kumar - Director
- Punam Devi - Director
The latest financial statements of Fiorallo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Fiorallo Pharmaceuticals is 10AADCF5378C1Z2, registered in Bihar.
The CIN (Corporate Identification Number) of Fiorallo Pharmaceuticals is U51909UP2018PTC109380. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fiorallo Pharmaceuticals was incorporated on 18 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Fiorallo Pharmaceuticals by revenue are Biosense Pharmaceuticals Private Limited, Mcchem Pharmaceuticals Private Limited, Hoper Pharmaceuticals Private Limited, Orgone Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Arun Kumar was appointed as Director on 18 Oct 2018. Punam Devi was appointed as Director on 18 Oct 2018.
The registered office of Fiorallo Pharmaceuticals is at Shri Alok Johri SO Dr K S Johri 313 B Flat No. 302 3A Sector 3 Vaishali, Ghaziabad, Uttar Pradesh, India – 201010.
Fiorallo Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Fiorallo Pharmaceuticals is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.